Outcome of patients with dual-chamber pacemakers implanted for the prevention of neurally mediated syncope

American Journal of Cardiology

Volumn 91, Issue 5, 2003, Pages 565-569

  Raj, Satish R ^a   Koshman, Mary Lou ^a   Sheldon, Robert S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; RECURRENT DISEASE; SYNCOPE; TILT TABLE TEST; TREATMENT OUTCOME;

EID: 0037374440     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03307-6     Document Type: Article

References (20)

1. Chen L.Y., Shen W.K., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J. Prevalence of self-reported syncope an epidemiologic study from Olmsted County, MN . (abstr) J Am Coll Cardiol. 39:2002;114A-115A.
2. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., Barsotti A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents a controlled study . Circulation. 100:1999;1798-1801.
3. Ector H., Reybrouck T., Heidbuchel H., Gewillig M., Van de Werf F. Tilt training a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance . PACE. 21:1998;193-196.
4. Mangru N.N., Young M.L., Mas M.S., Chandar J.S., Pearse L.A., Wolff G.S. Usefulness of tilt table test with normal saline infusion in management of neurocardiac syncope in children. Am Heart J. 131:1996;953-955.
5. Di Girolamo E., Di Iorio C., Sabatini P., Leonzio L., Barbone C., Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope a randomized, double-blind, placebo-controlled study . J Am Coll Cardiol. 33:1999;1227-1230.
6. Cox M.M., Perlman B.A., Mayor M.R., Silberstein T.A., Levin E., Pringle L., Castellanos A., Myerburg R.J. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol. 26:1995;1293-1298.
7. Mahanonda N., Bhuripanyo K., Kangkagate C., Wansanit K., Kulchot B., Nademanee K., Chaithiraphan S. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 130:1995;1250-1253.
8. Perez-Lugones A., Schweikert R., Pavia S., Sra J., Akhtar M., Jaeger F., Tomassoni G.F., Saliba W., Leonelli F.M., Bash D., Beheiry S., Shewchik J., Tchou P.J., Natale A. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope a randomized control study . J Cardiovasc Electrophysiol. 12:2001;935-938.
9. Connolly S.J., Sheldon R., Roberts R.S., Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 33:1999;16-20.
10. Sutton R., Brignole M., Menozzi C., Raviele A., Alboni P., Giani P., Moya A. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators . Circulation. 102:2000;294-299.
11. Ammirati F., Colivicchi F., Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope a multicenter, randomized, controlled trial . Circulation. 104:2001;52-57.
12. Sheldon R., Rose S., Flanagan P., Koshman M.L., Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 93:1996;973-981.
13. Sheldon R., Koshman M.L., Wilson W., Kieser T., Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol. 81:1998;158-162.
14. Morillo C.A., Klein G.J., Zandri S., Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J. 129:1995;901-906.
15. Sheldon R., Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol. 19:1992;773-779.
16. Malik P., Koshman M.L., Sheldon R. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result. J Am Coll Cardiol. 29:1997;1284-1289.
17. Moya A., Brignole M., Menozzi C., Garcia-Civera R., Tognarini S., Mont L., Botto G., Giada F., Cornacchia D. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 104:2001;1261-1267.
18. Kurbaan A.S., Franzen A.C., Heaven D., Mathur G., Bowker T.J., Petersen M., Sutton R. Cardioinhibition during tilt testing identifies patients who may benefit from pacing. PACE. 23:2000;1792-1794.
19. Petersen M.E., Chamberlain-Webber R., Fitzpatrick A.P., Ingram A., Williams T., Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J. 71:1994;274-281.
20. Sheldon R., Rose S. Components of clinical trials for vasovagal syncope. Europace. 3:2001;233-240.